摘要
Angiogenesis in glioma is associated with the poor prognosis of the disease and closely correlates with the highly invasive phenotype of glioma cells, which represents the most challenging impediment against the currently glioma treatments. Bmi-1, an onco-protein, has been implicated in the progression of various human cancers, including gliomas, whereas its role in glioma angiogenesis remains unclear. Our current study examined the effects of Bmi-1 on glioma angiogenesis in vitro as well as in vivo. We found that overexpression of Bmi-1 enhanced, whereas knockdown of Bmi-1 diminished, the capability of glioma cells to induce tubule formation and migration of endothelial cells and neovascularization in chicken chorioallantoic membrane. In vivo, Bmi-1 overexpression and knockdown, respectively, promoted and inhibited angiogenesis in orthotopically transplanted human gliomas. Furthermore, NF-kappa B activity and VEGF-C expression was induced by Bmi-1 overexpression, whereas Bmi-1 knockdown attenuated NF-kappa B signaling and decreased VEGF-C expression. Additionally suppression of NF-kappa B activity using a specific chemical inhibitor abrogated the NF-kappa B activation and the pro-angiogenic activities of glioma cells. Together, our data suggest that Bmi-1 plays an important role in glioma angiogenesis and therefore could represent a potential target for anti-angiogenic therapy against the disease.
- Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathwayJiang Lili; Wu Jueheng; Yang Yi; Liu Liping; Song Libing; Li Jun; Li Mengfeng*BMC Cancer, 2012, 12: 406.被引 18
- Oncoprotein Bmi-1 Renders Apoptotic Resistance to Glioma Cells through Activation of the IKK-Nuclear Factor-kappa B PathwayLi Jun; Gong Li Yun; Song Li Bing; Jiang Li Li; Liu Li Ping; Wu Jueheng; Yuan Jie; Cai Jun Chao; He Mian; Wang Lan; Zeng Musheng; Cheng Shi Yuan; Li Mengfeng*AMERICAN JOURNAL OF PATHOLOGY, 2010, 176(2): 699-709.被引 46
- TGF-beta induces miR-182 to sustain NF-kappa B activation in glioma subsetsSong Libing; Liu Liping; Wu Zhiqiang; Li Yun; Ying Zhe; Lin Chuyong; Wu Jueheng; Hu Bo; Cheng Shi Yuan; Li Mengfeng; Li Jun*Journal of Clinical Investigation, 2012, 122(10): 3563-3578.被引 46
